Similarly, a study on patients with COVID-19 with altered liver enzymes showed how treatment with hydroxychloroquine, remdesivir, lopinavir/ritonavir and tocilizumab were associated with an elevation of ALT five times the ULN [4]. This evidence concerns the gene GPT and COVID-19.